Skip to main content
logo
Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
31.96
+0.14 (0.44%)
At close: Jul 28, 2026, 4:00 PM EDT
31.60
-0.36 (-1.13%)
Pre-market: Jul 29, 2026, 5:11 AM EDT

Parabilis Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Cash & Equivalents
27.7147.28
Short-Term Investments
-40.69
Cash & Short-Term Investments
27.7187.98
Cash Growth
-68.50%-
Other Receivables
-0.36
Total Trade Receivables
-0.36
Other Current Assets
1.653.87
Total Current Assets
29.3692.21
Net Property, Plant & Equipment
46.0852.93
Other Long-Term Assets
5.394.12
Total Assets
80.82149.25

Liabilities

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Accounts Payable
17.279.51
Accrued Expenses
18.6313.52
Current Portion of Long-Term Debt
13.082.5
Current Portion of Leases
7.816.88
Total Current Liabilities
56.7932.41
Long-Term Debt
-12.79
Long-Term Leases
37.8144.03
Other Long-Term Liabilities
2.743.58
Total Long-Term Liabilities
40.5560.4
Total Liabilities
97.3492.81

Shareholders' Equity

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Additional Paid-in Capital
15.0111.66
Accumulated Other Comprehensive Income
-0.02
Retained Earnings
-541.5-395.62
Total Common Shareholders' Equity
-526.5-383.94
Minority Interest
509.97440.38
Shareholders' Equity
-16.5256.44
Total Liabilities & Equity
80.82149.25

Additional Metrics

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Total Debt
58.766.2
Net Cash (Debt)
-30.9921.78
Net Cash Growth
--
Net Cash Per Share
-15.3211.26
Book Value
-526.5-383.94
Book Value Per Share
-260.23-198.49
Tangible Book Value
-526.5-383.94
Tangible Book Value Per Share
-260.23-198.49
SEC Filings: 10-K · 10-Q